(Q44165230)

English

Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

author name string

Lance A Smith

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Banu C Tel

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Michael J Jackson

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Matthew J Hansard

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Rogelio Braceras

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Céline Bonhomme

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Claire Chezaubernard

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Susanna Del Signore

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sarah Rose

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Peter Jenner

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

887-901

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Levodopa-induced dyskinesia: review, observations, and speculations

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Evidence for a new type of dopamine receptor stimulating agent.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Tremor and Involuntary Movements in Monkeys: Effect of L-Dopa and of a Dopamine Receptor Stimulating Agent

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Differential labelling of dopamine receptors in rat brain in vivo: Comparison of [3H]piribedil, [3H]S 3608 and [3H]N,n-propylnorapomorphine

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Parkinson Disease Treated With a Suspected Dopamine Receptor Agonist

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Cabergoline, a long-acting dopamine D2-like receptor agonist, produces a sustained antiparkinsonian effect with transient dyskinesias in parkinsonian drug-naive primates.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Induction of chorea and dystonia in parkinsonian primates

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

The ALS patient care database: goals, design, and early results. ALS C.A.R.E. Study Group

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Omega-conotoxin GVIA-resistant neurotransmitter release from postganglionic sympathetic nerves in the guinea-pig vas deferens and its modulation by presynaptic receptors

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

cDNA sequence of human beta-preprotachykinin, the common precursor to substance P and neurokinin A

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Isolation and structural organization of the human preproenkephalin B gene

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Pramipexole-induced somnolence and episodes of daytime sleep

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Thalamo-striatal deafferentation affects preproenkephalin but not preprotachykinin gene expression in the rat striatum

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Kinetics of piribedil and effects on dopamine metabolism: hepatic biotransformation is not a determinant of its dopaminergic action in rats

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10200

21 January 2018

Identifiers

10.1002/MDS.10200

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44165230&oldid=2107336773"